VISITECT® CD4 Advanced Disease receives ERPD Approval
VISITECT® CD4 Advanced Disease supports the identification of advanced disease in people living with HIV. VISITECT® CD4 Advanced Disease is a unique, instrument-free, rapid and disposable CD4 test benefiting patients and healthcare providers.
Contact us for more information
Focus on unique VISITECT® CD4 rapid tests enabling access to people living with HIV in low- and middle-income countries
Point-of-care and laboratory-based solutions for food intolerance and gut health
Focus on lab automation through a strategic partnership with IDS. Expanding the menu of allergens
Omega (AIM: ODX), the medical diagnostics company focused on CD4, food intolerance and allergy testing announces that it has signed a Memorandum of Understanding...
Read more
MEDICA 16-19 November 2020, Düsseldorf, Germany
AACC Annual Scientific Meeting & Clinical Lab Expo 15-17 December 2020, Chicago, Illinois